<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Approximately 25% of <z:e sem="disease" ids="C0007785" disease_type="Disease or Syndrome" abbrv="">cerebral infarction</z:e> is cardioembolic in nature </plain></SENT>
<SENT sid="1" pm="."><plain>Transoesophageal echocardiography is widely regarded as the initial study of choice for evaluating cardiac source of embolism </plain></SENT>
<SENT sid="2" pm="."><plain>We studied the records of 83 consecutive patients referred to our Neurologic Ward between January 2000 and October 2006 with diagnosis of ischemic cerebrovascular disease of unknown cause (cryptogenetic <z:hpo ids='HP_0001297'>strokes</z:hpo>) </plain></SENT>
<SENT sid="3" pm="."><plain>A potential cardiac of emboli source was found in 36.1% of the patients </plain></SENT>
<SENT sid="4" pm="."><plain>Atrial septal abnormalities and aortic plaques accounted for most of the detected findings </plain></SENT>
<SENT sid="5" pm="."><plain>Our experience suggests that routine transoesophageal echocardiography in this setting is of value and has a high impact on clinical management </plain></SENT>
</text></document>